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Patient reports or ratings are essential for measuring the quality of patient care. Measures designed for this purpose
tend to focus on the processes and structures of care rather than the outcomes of it. The latter is arguably the
most valid indicator of the quality of care patients receive. Typically this information is gathered by probing patient
satisfaction with treatment as part of an investigation of satisfaction with hospital care. More recently patient ratings
of the outcome of treatment have been obtained to measure treatment efficacy in clinical trials. However, a more
direct approach is to ask patients to assess the benefit of treatment on their current health status. We performed a
structured literature review on patient reported satisfaction with outcomes of treatment and direct patient
assessments of the same. The purpose of this was to identify suitable candidate questions for a short instrument to
tap patient evaluations of in-patient hospital interventions. Articles were included if they dealt with patient
satisfaction or patient assessment of the outcomes of treatment. Articles were excluded if they dealt more generally
with patient satisfaction with care. We identified 169 papers, 79 were included in the review. The findings of this
review suggest that there are a number of benefits of directly asking patients to assess the outcome of hospital
treatment. Importantly this approach reflects outcomes relevant to the patient and is also more likely to reflect
patient report in routine clinical practice. There is also evidence that such approaches have face validity and
construct validity. The problems associated with this approach (i.e. response bias), are those common to patient
reported outcome surveys, but employing appropriate strategies can minimize them. Furthermore, employing a
simple set of questions that asks patients to assess the outcomes of treatment they receive can be time and re-
source efficient in comparison to administering lengthy measures. This approach could be tested for potential gen-
eric use as an evaluative measure for patients in hospital settings.
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The importance of measuring Patient Reported Out-
comes (PROs) in health is now widely accepted, and
complements the data collected by clinical observation,
or by the assessment of a particular pathophysiological
process. In particular, patient reported outcome mea-
sures (PROMs) are essential for measuring the quality of
medical or hospital care patients receive. This can be
assessed in relation to structural care provider characte-
ristics e.g. organisational setting and resources, the pro-
cesses undertaken to provide care, and the outcome or
change in a patient’s health status resulting from the
intervention [1]. It is therefore surprising that until* Correspondence: helen.lloyd@dph.ox.ac.uk
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reproduction in any medium, provided the orrecently patient evaluations have focused on the struc-
tures and processes of care, rather than the outcomes of
it, particularly since the latter are arguably the most
valid indicators of the quality of care received [2].
Patient ratings of improvements or outcomes of treat-
ment have commonly been obtained by eliciting patients’
perceptions as part of an investigation of satisfaction
with hospital care. More recently patient ratings of the
outcome of treatment have been obtained to measure
treatment efficacy in clinical trials [3]. Another mecha-
nism for investigating PROs is by directly asking patients
to evaluate the impact of treatment on their current
health status. This is often achieved by using a global as-
sessment question or transition question which asks pa-
tients to compare their current health status with that of
a pre-treatment time point.td. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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proaches described in the literature that have been used
to elicit patient reports of the outcomes of treatment,
and identify the key advantages and disadvantages of
their use. This was to identify suitable candidate ques-
tions for a measure to tap patient evaluations of hospital
treatment. To do this we carried out a structured review
of the literature and focused on articles concerned with
patient satisfaction with the outcomes of treatment or
direct patient assessment of the same.Methods
We used a dual search procedure to identify articles:
search (1) focused on the literature concerning patient
satisfaction with the outcomes of treatment, and search
(2) focused on the literature on transition questions or
similar approaches. A search of Scopus and PubMed
(all entries since 1970) was performed using combined
terms. We also identified key articles and searched their
reference lists. We screened articles detailing empirical
studies, reviews, consensus statements and expert reports
that either, assessed, investigated or discussed patient
satisfaction with the outcomes of treatment or transition
items/questions. Papers were excluded unless they de-
scribed approaches to garner patient satisfaction with
treatment or transition questions and related approaches
(see Figure 1). We were explicitly interested in the
methodological issues associated with these approaches
e.g. advantages/problems (biases etc.).‘Transition items/questions’ 
search returned 53 papers
Excluded 50 
papers = 
‘not 
relevant’
Reference lists of 3 papers 
reviewed  = 22 papers 
identified
Reference lists of 22 papers 
reviewed = 10 papers identified
Excluded N. 
3 papers = 
‘not 
relevant’
Total of number of relevant 
papers included in review = 32
Total of number of
included in r
Figure 1 Consort diagram of review process.Findings
Article identification process
An initial scope of the PROM literature suggested that
relevant papers would be found in two literature clusters;
the treatment satisfaction literature and papers using or
discussing transition items/external anchor questions/
global judgements to validate a PROM measure. A
search of the databases described above identified 53
articles relating to transition questions or related questions
(i.e. global evaluative judgements). We excluded 50 papers
as they contained the word ‘transition’ but did not contain
a measure or questions of a transition type. From the refe-
rence lists of the 3 remaining papers 22 additional papers
were produced, of these 3 were excluded for the same rea-
sons as above. Of the remaining 22 papers 10 additional
papers were identified and included, resulting in 32 papers
that were included in the transition item review.
Ten key papers concerning patient satisfaction with
the outcomes of treatment were identified from a review
of the above databases. Scrutiny of their reference lists
produced 74 papers of possible relevance, of these 37 were
excluded because they dealt more broadly with the patient
satisfaction. We therefore included 47 papers in this strand
of the review. A total of 79 papers from both search
streams were therefore the subject of the combined review.
Approaches to elicit patient reports on the outcomes
of treatment
Our literature review confirmed that the two most
commonly used approaches to elicit patient reports on‘Satisfaction with Outcome of 
Treatment’ search returned 10 
key papers
Excluded 
37 
papers = 
‘not 
relevant’ 
or ‘too 
broad in 
scope’
Reference list of 10 key papers 
reviewed = 74 papers identified
Total of number of relevant 
papers included in review = 47
 relevant papers 
eview = 79 
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satisfaction and measures which employed global ratings of
improvement. Other approaches exist which, while not
strictly within the scope of this review deserve highlighting.
One such approach is to measure the outcomes of
treatment against patient specific valued goals, an ex-
ample of which is the Patient Generated Index (PGI)
[4]. Such measures allow for an assessment of the benefit
of treatment against patient specific expectations, often
employing a more complicated format with sets of linked
transition questions. Such measures may be particularly
good at detecting clinically significant change over time,
but their complexity may render them less readily useful
for some patient populations. This review therefore focused
the two most commonly used approaches.
Measures of Patient Satisfaction with the outcomes of
treatment are used frequently, and often as a conse-
quence of the importance of collecting clinical trial data
with an interest in treatment outcomes important to pa-
tients. A second approach is to use a Global Rating of
Improvement to assess the benefits of a treatment re-
ceived; this often takes the form of an overall evaluative
question. Health Transition Question(s) (HTQs) are a
type of global evaluation question which directly ask
patients to assess whether their health or functioning
has stayed the same, improved or worsened when com-
pared with a previous (often pre intervention) time point.
The latter two approaches reflect a steer away from the
construct of satisfaction in recognition of problems asso-
ciated with this approach e.g. positive skews in data. The
following sections of this paper present a selection of
findings from the literature review that serve as typical
examples of these approaches. Table 1 details a selection
of measures that are good examples of well validated and
robust measures used to elicit patient reports of the out-
comes of treatment. The latter sections of the review out-
line the advantages and disadvantages of using such
approaches and potential strategies to consider when
using these methods.
Measures of treatment satisfaction
Within the treatment satisfaction literature we identified
three methods commonly used; a single global evaluation
question i.e. “How satisfied are you with your current
treatment?” a set of separate measures for each aspect of
treatment received, and a composite measure comprising
of a global item and a set of separate items [29].
Treatment satisfaction measures also usually include a
Likert scale with some also including a visual analogue
scale (VAS).
Patient satisfaction with outcomes of treatment has
been measured in a vast array of health conditions and
procedures. In particular, the fields of diabetes care
[5,6,30], orthopaedic surgery [8-10,31], renal treatment[32] and asthma [33] have been fruitful areas for this re-
search, and stand out for applying methodological rigour
in the development of measures to assess this (see
Table 1). The acceptability of treatments has also been
measured in relation to behavioural treatments for chil-
dren with conduct disorders [34] and mental health
treatments [35].
Global ratings of improvements/change and health
transition questions
As a consequence of some of the problems associated
with the data on satisfaction (i.e. positive data skews and
undifferentiated data sets), researchers have developed
other approaches to obtain this information. The main
alternative is to gather patient ratings of improvement
or assessments of health change in response to treat-
ment i.e. “Overall, how would you compare your health
with the way it was before your surgery, is it much better
now, a little better now, about the same, a little worse or
much worse?”.
One such approach is to collect a Global Rating of
Change (GRC) related to treatment. This approach pro-
vides an opportunity for patients to combine all of the
components of their experience (e.g. pain relief, im-
provements in functioning) into one overall evaluative
measure of the treatment they receive [19]. These ap-
proaches have also been used to investigate participants’
judgments of the clinical importance of change in other
outcome measures [14,36]. These questions are com-
monly used as an external anchor by which to assess the
responsiveness of measure to patient rated meaningful
health change (See the FACT (Functional Assessment of
Cancer Therapy questionnaire and Health Related Qua-
lity of life in a study of oncology patients [15])). Global
ratings of change have also been used to elucidate clini-
cally important changes in scores in quality of life of in-
struments in chronic heart and lung disease [37,38], in
asthma [38] and cancer treatment [39]. Indeed, Jaeschke
et al. (1989) concluded that in the absence of a gold
standard measure external global ratings represent a
credible alternative for establishing the meaning of
change in a new measure [37].
An example of a measure specifically designed for this
purpose is the Patient Global Impression of Change
Scale (PGIC) [13]. This rating scale measures patient
evaluations of their health change in relation to treat-
ment from “very much improved” to “very much worse”
using a visual analogue scale, and has two variants; one
for use by the clinician and one for use by the patient.
The PGIC has been used in trials of chronic pain [17,18]
and recommended as a core outcome measure of global
improvement [19].
Central to the importance of measuring PROs are
methods that assess the changes in health related status
Table 1 A selection of well designed measures to elicit patient report of the outcomes of treatment
Type of approach Title Description Comments on psychometric properties
Satisfaction with/
assessment of the
outcomes of treatment
Diabetes Treatment
Satisfaction Questionnaire
(DTSQ). [5]
An 8 item measure of patient
satisfaction with diabetes
treatment.
Developed by qualitative work to ensure
comprehensive and authentic issues were
covered. Assessed psychometrically and
analysed in relation to covariates.
DTSQc [6] Revised version of the above. Detects greater responsiveness to
improvements than the original DTSQ.
Oxford Elbow Score (OES) [7] A 12-item PRO developed to
assess the outcomes of elbow
surgery.
Shown to be valid, reliable and sensitive
to change after rigorous testing.
Questionnaire on the perceptions
of patients about shoulder
surgery. [8]
A 12-item PRO for patients
having shoulder operations.
A short, practical, reliable, valid outcome
measure that is sensitive to clinically
important changes.
Questionnaire on the perceptions
of patients about total hip
replacement. [9]
A 12-item PRO for patients having
total hip replacement (THR).
As above.
Questionnaire on the perceptions
of patients about total knee
replacement. [10]
A 12-item questionnaire for
patients having a total knee
replacement (TKR).
As above.
Measures containing
transition items/global
ratings of change
The Evaluation Ranking Scale
(ERS) [11]
The ERS asks patients to rank and
then rate six dimensions or
characteristics of the services
they have received.
Compared with a global measure of
satisfaction the ERS was more specific,
more discriminating, and resulted in
lower satisfaction scores [11].
Patient Judgements of Hospital
Quality (PJHQ) [12]
Designed to assess the health
change associated with hospital
stay/treatment over 11 scales.
This measure was subject to extensive
and rigorous devolvement and testing
that included patient reported open-ended
responses about the quality of hospital care,
and interviews with hospital administrators,
physicians and nurses [12].
Patient Global Impression of
Change Scale (PGIC) [13]
Measures patient evaluations
of their health change in
relation to treatment.
Captures what patients consider to be
important changes in pain ratings [14]
and cancer specific quality of life scores
[15,16]. Also a potential correlate of clinical
opinion [17]. Used in trials of chronic pain
[17,18] and recommended as a core
outcome measure of global
improvement [19].
The Functional Status Index
(FSI) [20]
A patient specific measure of
change in maximal physical,
mental, and emotional function
with a transition component that
measures change from patient
specific norms.
As part of the development it was
compared with the Sickness Impact
Profile (SIP) [21] and performed well,
showing sensitivity to change over
time [22].
The Health Transition Index
(HTI) [23]
Patient rated change in health
between two time periods using a
5 point ordinal scale (1 = much better
than a year ago; 2 = somewhat better
than a year ago; 3 = about the same;
4 = somewhat worse than a year ago;
and 5 = much worse than a year ago)
HTI was used as an external anchor
to assess the responsiveness of the
SF36 [23], the HAQ [24] and a disease
specific health status measure AIMS2
[25] in psoriatic arthritis [26] and
detected as much change as clinical
examination [26].
Short Form 36 (SF36) [23] The SF-36 is a health survey with
36 questions. It yields an 8-scale
profile of functional health and
well-being scores as well as
psychometrically-based physical and
mental health. The HTQs have five
response categories from “much
better” to “much worse”.
The HTQ was assessed among a large
general practice sample and correlated
well with change measured prospectively
[27]. The discriminative properties of the
HTQs were demonstrated in a similar
large population study against prospective
change [28]. This study was able to
successfully distinguish groups whose
health had improved compared to those
whose health deteriorated.
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by directly asking patients to assess whether they con-
sider their health or functioning to have stayed the same,
improved or worsened compared with a previous (often
pre intervention) time point i.e. “The last time we talked,
you said that (physical activity from the baseline index
or previous transition) was the most physically strenuous
thing you could do? In terms of physical activity now are
you: much better, slightly better, the same, slightly worse
or much worse?”.
HTQs are employed in a number of ways in health sta-
tus measurement, and with the exception of studies that
have assessed a HTQ within a measure [27,28,40-42], and
the exception of several notable papers [43-45] there has
been little discussion of the widespread use of these ques-
tions. This is perhaps a reflection of their perceived useful-
ness in the absence of a gold standard, much like global
questions, they are often used as an external measure or
benchmark by which to compare the responsiveness of an
existing measure [15,37,46-51], or during development
of a new measure [7-10,22,52,53]. Studies conducted for
the latter purposes thus perform indirect assessments of
HTQs in the process of using them as the external bench-
mark. Studies that directly assess a HTQ within a scale
often do this by measuring change assessed prospectively,
i.e. by calculating change scores in samples known to have
experienced a clinically important change compared to
those that have not experienced such a change [28]. Pa-
tient and clinician ratings of patient health change were
collected to assess the responsiveness of the Sickness Im-
pact Profile (SIP) and the American Rheumatism Asso-
ciation (ARA) functional scale [44]. This study found
that only changes in SIP physical dimension and patient
self-rating showed significant correlation with clinically
estimated changes, and that transition items registered
changes in clinical status that were not detected by the
functional scales [54]. The benefit of using HTQs to probe
patient evaluation has been acknowledged by several au-
thors [41,53], mainly as a result of their validity and practi-
cality. Further support for HTQs is provided by studies
that assess health status measures against HTQs and
standard clinical measurement [24,36,41,42,48,49].
Discussion
Advantages of eliciting perceptions of satisfaction with
the outcomes of treatment or transition items/global
ratings of improvement
The findings of this review suggest that there are a num-
ber of advantages to using the above approaches for
evaluative purposes. Particularly when short measures are
employed or single global questions are grouped with
HTQs that probe experiences of adverse events or side ef-
fects. For example, to assess the accuracy and sensitivity
of measures designed to specifically probe PROs inorthopaedic surgery, treatment satisfaction questions have
been posed alongside direct HTQs as an external anchor
[7,8]. This form of a HTQ is routinely used to assess the
sensitivity of outcome measures in medicine [53,55] and
more specifically patients with arthritis [54]. Using such a
combination will help ensure that core domains cited in
the literature related to treatment outcomes are covered.
The main advantages are outlined below:
They reflect outcomes relevant to the patient
Dawson et al. [52] found that patient satisfaction with
surgery poorly correlated with clinician ratings at follow
up, and therefore provided more evidence of the diffe-
rence between patients’ and clinicians’ perceptions of
which aspect of outcome to rate as important [56,57].
They reflect patient reports in routine clinical practice
There is evidence that retrospective questions that probe
satisfaction with outcomes of treatment (or perceptions of
the same) reflect patient report in routine clinical practice
and are therefore easier to incorporate into clinical deci-
sion making and care [46]. Support for this comes from a
variety of studies across clinical specialties [58].
Face validity
The use of HTQs and treatment outcome questions as an-
chors to assess the responsiveness, reliability and validity
of numerous disease specific [7,52] and generic measures
[22,26,27,51] suggests that these questions do have an ac-
ceptable level of face validity. The development of several
measures to elicit patient report of hospital stay (PJHQ &
ERS) [11,12] and patient rated clinical change (PGCI &
GROC) [13,37] have also been subject to content vali-
dation with patients to understand the meanings they
ascribe to the questions posed.
Construct validity
Evidence to suggest that retrospective items of treatment
outcome have construct validity has been reported from
studies of hip replacement (THR) surgery [59], lower
back pain [47,60], and diabetes [5,30]. Generic measures
such as the PJHQ, the PGCI and the ERS also capture
the perceptions of treatment success across a range of
interventions and health conditions, with the majority of
evidence from studies assessing the PGCI (ibid).
Sensitive to change
Retrospective measures of change in health may be more
sensitive to change than serial measures [36]. Several
studies have also demonstrated that transition items
register changes in clinical status that were not detected
by the functional scales [54], and are better at discrimin-
ating the health status of patients than generic measures
[50]. Studies that have compared measures that contain
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detect clinically important change comparable to that
detected by clinical endpoints [61] and better than cal-
culated change scores in health-related quality of life
[36,42]. In addition, external transition questions may be
better at recognising deterioration in sub groups of pa-
tients than a generic measure [42].
Less demanding in time and resources
Directly asking patients to retrospectively assess the
benefit of treatment or change in their health status is
less demanding in resources than collecting prospective
data [6,62]. For example, a meta-analysis of 150 pain
treatment studies concluded that a global measure of
treatment efficacy provides similar data to that derived
from hourly measurements, and that the pooling of data
permitted the determination of the absolute and relative
efficacy of pain treatment for a substantial number of
patients (e.g. 1000 or more) [63]. Compared with the
cost and labour implications of using traditional pro-
spective measures this method could contribute a sub-
stantial cost and labour saving for the NHS.
Problems with these methods
There are however a number of problems with using
these methods. Global evaluation questions tend to be
crude and not accurately reflect satisfaction (which is
often an amalgamation of several topics) thus masking
differentials. Conversely, lengthy questionnaires can be
burdensome for routine treatment evaluations. The most
notable problems associated with using the above ap-
proaches are:
Non-response bias
A review of patient evaluations of hospital care reported
similar factors to those mentioned in the literature that
influence response rates in satisfaction surveys [64]. For
example, non-response bias was found to positively skew
results, and while little is known about why people fail
to respond to surveys, there is some evidence that it is
related to illness severity (ibid).
Acquiescent response bias
Positive skews in data sets may also be a consequence of
acquiescent responses, which are common problems with
PROMs [3]. However, patient response in surveys that
focus on satisfaction with treatment may be a greater risk
of these biases since as a construct it is intrinsically more
judgement laden. Positive skews may be related to met-
hodological problems such as poorly worded items [3].
Present state and recall bias
Retrospective items have been found to produce more
favourable results than prospectively monitored healthstatus data from the same patients [63,65]. This may be
due to present state bias with retrospective judgements.
However, retrospective questions that are least likely
to be influenced by present state bias are transition
questions [59].
The role of expectations
Different populations have different values, expectations
and experiences, and these are likely to influence the re-
sults of patient surveys of satisfaction with treatment
outcomes, or change in health status as a consequence
of treatment. Particularly treatment satisfaction questions,
as differing expectations have been shown to predict over-
all satisfaction [66], and expectations are likely to be influ-
enced by a range of patient and socio-economic variables.
Research on patient satisfaction attempts to overcome the
effect of this by collecting baseline data and controlling
for the influence of these factors [3]; however, in routine
clinical settings this is unlikely to be possible.
Timing of survey
The point at which the measure is completed is likely to
influence the response rate/responses provided - the
consensus is that surveys should be conducted as soon
after the medical encounter as possible to minimise re-
call bias [64,67,68]. There is evidence that HTQs used
for clinical evaluative purposes in the short term (i.e. 12
weeks or less), may therefore be less likely to suffer from
recall and non-response biases [40].
Question types and & response formats
There are two types of question routinely used to survey
patients with regards to their hospital or treatment expe-
riences; ratings and reports. The former are inherently
more subjective and involve an evaluative element (i.e.
are you satisfied with the outcome of your treatment?),
and the latter are intentionally factual, more objective,
and directly ask patients the extent to which their health
has changed as a consequence of treatment (i.e. did the
treatment that you received improve health?) [69]. Re-
ports produce more variability and less skew, and are less
likely to be associated with patient socio-demographic var-
iables than ratings [64]. Therefore, questions that directly
ask patients the extent to which an intervention has
helped improve their health, or that probe their direct ex-
perience of treatment may be less subject to bias than
questions that ask patients how satisfied they are with the
outcomes of their treatment [69,70].
Responses to questions posed in surveys are generally
categorical or numerical. Responses that range from
“very satisfied” to “very unsatisfied” are the most com-
monly used rating style in satisfaction with treatment
surveys. However, there are number of problems associ-
ated with these responses, for example a change from
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lation of small shifts in separate component areas or
large shifts in a single component [67]. Furthermore, re-
sponses to this form of rating tend to fall into two nar-
row bands, being only superficially indicative of high
satisfaction. Whilst a substantial change in ratings is
usually obvious for certain interventions such hip re-
placement etc., a change in ratings may be less marked
when small and subtle health status changes occur i.e. in
cancer patients or patients with long term conditions.
Numerical and continuous scoring of satisfaction rat-
ings using a Likert-type scales may provide a high degree
of precision, but it should be remembered that actual
values may be small and that these are not intervals [71].
This approach therefore risks providing a sense of
pseudo-precision [71].
Responses can also be weighted according to their rela-
tive importance to the patient [67], however a problem
with this method arises when the direct approach is used,
as patients assign a numerical value of importance of
equal numbers to each dimension [72]. The indirect ap-
proach requires the researchers to assign weightings by
studying patient responses, but this method is flawed since
it is difficult to extract information about how patients
weigh and combine individually different dimensions to
give their response [73]. The above problems bring into
question the use of an amalgamated overall satisfaction
score, namely that it provides over inflated results and
masks areas of dissatisfaction with health care [30].
The response format used for the PJHS was that
adopted from the Medical Outcome Study i.e. a 5-point
rating from ‘excellent’ to ‘poor’ [74]. The authors used this
format as it measured patient ratings of quality rather than
satisfaction or other attitudes, they also reported that it
performed well psychometrically and allowed for direct
comparison between features of care [11]. The patient
PGIC and many of the Oxford Measures described above
use a similar approach (‘no change’ to ‘a great deal better’).
Patient differences
Patient factors have been shown to influence evaluations
of hospital care. For example, evidence from a meta-
analysis of socio-demographic factors and patient satis-
faction surveys of medical care, that older, white, male
patients, are more satisfied than other patients [75].
Greater self-perceived illness during in-patient stay has
also been associated with poorer evaluations of care [76].
Post hospitalisation surveys may also under-represent
males and older patients unless these groups are targeted
by more vigorous follow-up methods [77].
Methods to reduce bias
Methods to reduce bias in patient outcome surveys have
been described as a) the use of qualitative methods inthe design of the questionnaire, b) the use of patient re-
ports rather than ratings, c) a balance of questions using
both positively and negatively worded statements, and d)
questions posed with better response scales [3]. There-
fore the most important methodological consideration
relates to the type of questionnaire used. One which con-
tains open-ended questions will allow patients to specify
and comment on the areas of care that they are referring
to, whilst close ended questions gives a more quantitative
evaluation. Ideally a survey should include both [67].
Preferably, satisfaction with, or the assessment of the
outcomes of treatment should be measured multi-
dimensionally [29]. This is to avoid the problems of using
a single global measure which is likely to reflect numerous
features of the treatment received, and be closely related
to the quality of the care received [2]. In addition, multi-
item scales generally yield more score variability, and
higher reliability and validity scores than single items mea-
sures [78]. Ware et al. [79] also recommends self-
administration of measures to reduce data collection costs
and increase confidentiality, and placing questions about
overall satisfaction or quality of care after all questions of
a more specific nature.
Research on the reporting of health events has shown
that the likelihood of its report is related to the import-
ance of the event for the respondent [29]. Therefore the
under-reporting of events of less significance may due to
the fact that the information was not elicited by the data
collection method. The reporting of such events has
been improved by questionnaires that are designed to fa-
cilitate recall processes i.e. direct questions about a spe-
cific treatment process (ibid).
Conclusions
The findings of this review suggest that there are a num-
ber of benefits associated with combining a simple set of
questions to elicit patients’ assessments of the outcomes
of hospital treatment. Most importantly, asking patients
to directly assess the impact of the treatment that they
receive reflects outcomes relevant to the patient, which
can often differ from clinical and provider appraisals of
the same treatment or intervention. Directly asking pa-
tients to assess outcomes of treatment is also more likely
to reflect patient report in routine clinical practice, as it
is inherently natural for clinicians to ask patients ques-
tions in this way. The results of surveys using this type
of question may therefore be more readily translated
into clinical practice. There is also evidence in the litera-
ture that asking patients to assess the outcome of their
treatment has face validity. This is shown in the wide-
spread use of such questions, particularly transition ques-
tions as external anchors to assess the performance of
other PROMs. Furthermore, a number of well-developed
disease specific and generic measures using the same
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therefore provide some evidence of construct validity. The
advantages of using a simple set questions that ask pa-
tients to assess outcomes of treatment they receive also
appear to be borne out it in terms of how much time and
resources they save in comparison to administering and
analysing lengthy measures.
There are also a number of problems associated with
the above approaches that can result in positive data
skews. In balance however, it would appear that these
problems are associated with PRO surveys in general,
and there are strategies that can minimise these risks.
Firstly, the use of reports rather than ratings may help
increase variability in responses and minimise positive
skews. Furthermore, combining a simple transition ques-
tion as a temporal marker or probed recall aid, alongside
a retrospective global report of the outcomes of treat-
ment may overcome some of the problems associated
with recall and present state bias. The inclusion of a
question which probes the negative aspects of treatment
such as unexpected events or side effects will ensure that
all features of experience are covered. Timing the ad-
ministration of the questionnaire within the first three
months post intervention may also reduce non-response
bias, and minimise recall bias, and ensure that patients
less likely to respond (i.e. men) are prudently followed-
up, this may produce a more representative data set.
The findings from this review suggest that a simple set
of items that directly ask patients to assess the outcome
of their treatment could be tested for use as an evalu-
ative measure for generic use in a range of settings.
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